Status: Recruiting
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China
The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.
Participants needed: 1,000
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Sino Medical Sciences Technology Inc.Updated: Apr 1, 2025Locations: 5
Eligibility criteria
Males or females between 18 and 80 years of age; [+3]
Those who have surgery within previous 30 days or plan to perform major surgery... [+11]